Literature DB >> 3169589

Inhibition of intraocular proliferation by homoharringtonine. An experimental study.

J P Li1, C Z Hu, S Q Zeng, J M Ren, H R Wei.   

Abstract

Homoharringtonine, an alkaloid indigenous to China, was studied for its effect on fibroblast growth in cell culture and on intraocular proliferation produced in rabbits by injecting homologous fibroblasts into the vitreous. The results demonstrate that homoharringtonine reduced the cell growth by 50% at a concentration of 0.005 mg/l in vitro, significantly inhibited vitreous proliferation, and prevented the occurrence of retinal detachment in vivo. Light and electron microscopy revealed no ocular toxicity in drug-treated eyes. Homoharringtonine may be of considerable value in the prevention and treatment of intraocular proliferation in patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169589     DOI: 10.1007/bf02172969

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  Proliferations in the vitreous cavity after perforating injuries. A histopathological study.

Authors:  J Faulborn; T M Topping
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-02-22

2.  Control of experimental massive periretinal proliferation by daunomycin: dose-response relation.

Authors:  P Wiedemann; M Kirmani; M Santana; N Sorgente; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

3.  Models for assessing scar tissue inhibitors.

Authors:  F M van Bockxmeer; C E Martin; I J Constable
Journal:  Retina       Date:  1985 Winter-Spring       Impact factor: 4.256

4.  Taxol for the treatment of proliferative vitreoretinopathy.

Authors:  F M van Bockxmeer; C E Martin; D E Thompson; I J Constable
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-08       Impact factor: 4.799

5.  Intravitreal 5-fluorouracil in the prevention of post-traumatic vitreous proliferation.

Authors:  I Avni; M Belkin; A Hercberg; M Blumenthal
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

6.  Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation.

Authors:  M S Blumenkranz; A Claflin; A S Hajek
Journal:  Arch Ophthalmol       Date:  1984-04

7.  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

Authors:  Y Tano; D Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1980-12       Impact factor: 5.258

8.  Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil.

Authors:  S Binder; B Riss; C Skorpik; W Kulnig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

9.  Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.

Authors:  P Wiedemann; N Sorgente; C Bekhor; R Patterson; T Tran; S J Ryan
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

  9 in total
  1 in total

Review 1.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.